These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7984149)

  • 21. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells.
    Spanjaard RA; Sugawara A; Ikeda M; Chin WW
    J Biol Chem; 1995 Jul; 270(29):17429-36. PubMed ID: 7615548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A four-amino-acid insertion in the ligand-binding domain inactivates hRXRbeta and renders dominant negative activity.
    Mahajna J; Shi B; Bruskin A
    DNA Cell Biol; 1997 Apr; 16(4):463-76. PubMed ID: 9150434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of deoxyribonucleic acid sequences that bind retinoid-X receptor-gamma with high affinity.
    Dowhan DH; Downes M; Sturm RA; Muscat GE
    Endocrinology; 1994 Dec; 135(6):2595-607. PubMed ID: 7988448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoform-specific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland.
    Sugawara A; Yen PM; Qi Y; Lechan RM; Chin WW
    Endocrinology; 1995 Apr; 136(4):1766-74. PubMed ID: 7895689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of yeast reporter assay for screening specific ligands of retinoic acid and retinoid X receptor subtypes.
    Shiizaki K; Yoshikawa T; Takada E; Hirose S; Ito-Harashima S; Kawanishi M; Yagi T
    J Pharmacol Toxicol Methods; 2014; 69(3):245-52. PubMed ID: 24530888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterodimeric receptor complexes determine 3,5,3'-triiodothyronine and retinoid signaling specificities.
    Hermann T; Hoffmann B; Zhang XK; Tran P; Pfahl M
    Mol Endocrinol; 1992 Jul; 6(7):1153-62. PubMed ID: 1324421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
    Salbert G; Fanjul A; Piedrafita FJ; Lu XP; Kim SJ; Tran P; Pfahl M
    Mol Endocrinol; 1993 Oct; 7(10):1347-56. PubMed ID: 8264664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutively active retinoid receptors exhibit interfamily and intrafamily promoter specificity.
    Underhill TM; Cash DE; Linney E
    Mol Endocrinol; 1994 Mar; 8(3):274-85. PubMed ID: 8015546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.
    Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA
    Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different response to retinoic acid of two teratocarcinoma cell lines.
    Wan YJ; Wang L; Wu TC
    Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of nuclear retinoic acid receptors during mouse odontogenesis.
    Bloch-Zupan A; Décimo D; Loriot M; Mark MP; Ruch JV
    Differentiation; 1994 Sep; 57(3):195-203. PubMed ID: 7988794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
    Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
    J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two distinct actions of retinoid-receptor ligands.
    Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
    Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of the receptors for retinoic acid in prostatic adenocarcinoma.
    Kikugawa T; Tanji N; Miyazaki T; Yokoyama M
    Anticancer Res; 2000; 20(5C):3897-902. PubMed ID: 11268473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
    Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.